Patients on party drugs undergoing anesthesia

Current Opinion in Anaesthesiology

Volumn 16, Issue 2, 2003, Pages 147-152

  Steadman, Joy L ^a   Birnbach, David J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; Anesthesia; Cocaine; Drug abuse; Ecstasy; Heroin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 HYDROXYBUTYRIC ACID; ALCOHOL; AMPHETAMINE; ANESTHETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANNABIS; COCAINE; DIAMORPHINE; FLUNITRAZEPAM; ILLICIT DRUG; METHAMPHETAMINE; PHENCYCLIDINE; SUXAMETHONIUM; THIOPENTAL;

ANESTHESIA; ANESTHESIST; BRAIN EDEMA; BRAIN INJURY; BRAIN VASOSPASM; CARDIOTOXICITY; DETOXIFICATION; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; HEART INJURY; HUMAN; HYPERTHERMIA; IMMUNE SYSTEM; KIDNEY INJURY; LUNG INJURY; MEMORY; PAIN; PATIENT CARE; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC TRANSMISSION;

EID: 0037398096     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200304000-00007     Document Type: Review

References (63)

1. Nestler EJ, Hyman SE, Malenka RC. Reinforcement and addictive disorders in molecular neuropharmacology: a foundation for clinical neuroscience, chapter 16. New York: McGraw-Hill; 2001. An excellent resource for a receptor-level understanding of substance abuse. This book should be in every academic anesthesiologist's library. It has the fundamental neurochemical mechanisms of everything we know about the central and peripheral nervous systems.
2. Grossman M, Chaloupka FJ, Shim K. Illegal drug use and public policy. Health Aff (Millwood) 2002; 21:134-145. An overview of how drug abuse has created public policy and vice versa.
3. Saitz R, Mulvey KP, Plough A. Physician unawareness of serious substance abuse. Am J Drug Alcohol Abuse 1997; 23:343-354.
4. Miller PW, Mycyk MB, Leikin JB, Ruland SD. An unusual presentation of inhalant abuse with dissociative amnesia. Vet Hum Toxicol 2002; 44:17-19. During an 18-month work-up for seizures the patient never mentioned how the seizures were preceded by his inhalant abuse.
5. Brookoff D, Campbell EA, Shaw LM. The underreporting of cocaine-related trauma: drug abuse warning network reports vs. hospital toxicology tests. Am J Public Health 1993; 83:369-371
6. May J, White H, Leonard-White A. The patient recovering from alcohol or drug addiction: special issues for the anesthesiologist. Anesth Analg 2001; 92:1601-1608. An excellent discourse on issues such as sedation, pain control, and altered physiology.
7. Budai B, Iskandar H. Dextromethorphan can produce false positive phenoyclidine testing with HPLC. Am J Emerg Med 2002; 20:61-62. Cough syrup shows up as phenoyolidine as well as opioid.
8. Peace MR, Tarnai LD, Poklis A. Performance and evaluations of four on-site drug-testing devices for detection of drug abuse in urine. J Anal Toxicol 2000; 24:589-594.
9. Voroe SP, Sklerov JH, Kalsinsky KS. Assessment of the ion trap mass spectrometer for routine qualitative and quantitative analysis of drugs of abuse extracted from urine. J Anal Toxiool 2000; 24:595-601.
10. Klein J, Karaskov T, Koren G. Clinical applications of hair testing for drugs of abuse: the Canadian experience. Forens Sci Int 2000; 107:281-288.
11. DAWN Report (Drug Abuse Warning Network). www.SAMHSA.gov [Accessed 30 October 2002].
12. A comprehensive review of MDMA and GHB: two common club drugs. Pharmaootherapy 2001; 21:1486-1513. An excellent article on nearly every aspect of MDMA, including metabolites that could accumulate and wreak havoc. Includes pharmacokinetic data and how not all effects are dose dependent
13. Monitoring the Future Survey. www.NIDA.NIH.gov [Accessed 30 October 2002].
14. Dennison SJ. Clonidine abuse among opiate addicts. Psychiatr Q 2001; 72:191-195. Clonidine withdrawal by addicts abusing it to increase their high could result in lethal hypertensive changes.
15. Regional trends in drug abuse reporting. www.NIDA.NIH.gov [Accessed 30 October 2002].
16. Birnbach DJ, Browne IM, Kim A, et al. Identification of polysubstance abuse in the parturient. Br J Anaesth 2001; 87:488-490. An evaluation of a new immunodiagnostic assay that revealed a high prevalence of opioid abuse in cocaine-abusing patients.
17. Lai S, Lai H, Page JB. The association between cigarette smoking and drug abuse in the United States. J Addict Dis 2000; 19:11-23.
18. Kouri M, Stull M, Lukas SE. Nicotine alters some of cocaine's subjective effects in the absence of physiological or pharmacokinetic changes. Pharmacol Biochem Behave 2001; 69:209-217. Nicotine actually interferes with some of the sought-after effects of cocaine, which begs further research into nicotinic action in the brain.
19. Bagshaw SM, Hagen NA. Medical efficacy of cannabinoids and marijuana: a comprehensive review of the literature. J Palliat Care 2002; 18:111-122. A large review of the beneficial uses of cannabis as supported in the scientific literature.
20. Fant RV, Heishman SJ, Bunker EB. Acute and residual effects of marijuana on humans. Pharmacol Biochem Behav 1998; 60:777-784.
21. O'Leary DS, Block RI, Koeppel JA, et al. Effects of smoking marijuana on brain perfusion and cognition. Neuropsychopharmacology 2002; 26:802-816.
22. Haney M, Ward AS, Comer SD. Abstinence symptoms following smoked marijuana in humans. Psychopharmacology (Berl) 1999; 141:395-404.
23. Thompson CS, White RJ. Lung bullae and marijuana. Thorax 2002; 57:563.
24. Tashkin DP. Airway effects of marijuana, cocaine, and other inhaled illicit agents. Curr Opin Pulmon Med 2001; 7:43-61. An excellent overview of what inhaling common illicit substances does to the airways, with a great bibliography.
25. White SM. Cannabis abuse and Laryngospasm. Anaesthesia 2002; 57:622-623. Marijuana smoking is known to cause significant airway changes, and can precipitate laryngospasm.
26. Jarai Z, Kunos G. Cardiovascular effects of cannabinoids. Orv Hetil 2002; 143:1563-1568. CB-1 receptors cause vasodilation and bradycardia and may play a role in different types of shock.
27. Szyper-Kravitz M, Lang R, Manor Y. Early invasive pulmonary aspergiliosis in a leukemia patient linked to aspergillus contaminated marijuana smoking. Leuk Lymphoma 2001; 42:1433-1437. CB-2 receptors are expressed on immune cells, and smoking contaminated marijuana may make infection with unusual organisms easier.
28. Tuncel M, Wang Z, Arbique D, et al. Mechanism of the blood pressure-raising effect of cocaine in humans. Circulation 2002; 105:1054-1059. A brilliant piece on recreating the actual human experience of cocaine abuse (not anesthetized) and documenting the real cause of cocaine hypertension.
29. Mehta MC, Jain AC, Billie M. Effects of cocaine and alcohol alone and in combination on cardiovascular performance in dogs. Am J Med Sci 2002; 324:76-83. An interesting work on how two drugs may be synergistic in one combination and only additive in another.
30. Margolin A, Avants SK, Setaro JF, et al. Cocaine, HIV, and their cardiovascular effects: is there a role for ACE-inhibitor therapy? Drug Alcohol Depend 2000; 61:35-45.
31. Whittington R, Virag L, Vulliemoz Y, et al. Dexmedetomidine increases the cocaine seizure threshold in rats. Anesthesiology 1997; 3:693-700.
32. Lindholm S, Rosin A, Dahlin I, et al. Ethanol administration potentiates cocaine-induced dopamine levels in the rat nucleus aooumbens. Brain Res 2001; 915:176-184. Alcohol increases the dopamine reward from cocaine.
33. Oztezcan S, Dogru-Abbasoglu S, Mutlu-Turkoglu U, et al. The role of stimulated lipid-peroxidation and impaired calcium sequestration in the enhancement of cocaine induced hepatotoxioity by ethanol. Drug Alcohol Depend 2000; 58:77-83.
34. Mets B, Pantuok CB, Diaz J, Soo E. The effect of chronic cocaine administration on hemodynamic stability and neurohumoral mediators during isoflurane anesthesia and shock in rats. Acta Anaesthesiol Scand 2001; 45:377-384. After 13 days of cocaine, the rats were no different from controls in terms of the hormonal or hypotensive response to isoflurane.
35. Birnbach DJ. Interactions in anesthesia: anesthetic management of the drug abusing parturient. Acta Anaesth Belg 2001; 52:351-356. A review of the obstetric and anesthetic implications of drug abuse in the pregnant patient.
36. Wachtel S, Ortengren A, Wit H. The effects of haloperidol or risperadone on subjective responses to methamphetamine in healthy volunteers. Drug Alcohol Depend 2002; 68:23-33.
37. Fischer SP, Healzer JM, Brook MW, Brook-Utne JG. General anesthesia in a patient on long-term amphetamine therapy: is there a cause for concern? Anesth Analg 2000; 91:756-759.
38. Stibolt O, Wachowiak-Anderson G. Altered response to intravenous thiopental and succinyloholine in acute amphetamine abuse. Acta Anesthesiol Scand 2002; 46:609-610. Amphetamine in this case report seems to shorten drug effect, contrary to previous case reporting with cocaine and succinyloholine.
39. Rejali D, Glen P, Odom N. Pneumomediastinum following ecstasy ingestion in two people at the same rave. J Laryngol Otol 2002; 116:75-76. A highly probable link with no clear explanation.
40. Morgan MJ, McFie L, Fleetwood H, Robinson JA. Ecstasy: are the psychological problems associated with its use reversed by prolonged abstinence? Psyohopharmaoology (Berl) 2002; 159:294-303.
41. Buchert R, Obrooki J, Thomasius O, et al. Long-term effects of ecstasy abuse on the human brain studied by FDG PET. Nucl Med Commun 2001; 22:889-897. Adolescent or prolonged MDMA abuse produces long-lasting changes in glucose metabolism in the brain, despite abstinence.
42. O'Cain PA, Hletko SB, Ogden BA, Varner KJ. Cardiovascular and sympathetic responses and reflex changes elicited by MDMA. Physiol Behav 2000; 70:141-148.
43. Walsh T, Carmichael R, Chestnut J. A hyperthermic reaction to ecstasy. Br J Hosp Med 1994; 51:476.
44. Gill JR, Hayes JA, de Souza IS, et al. Ecstasy (MDMA) deaths in New York City: a case series and review of the literature. J Forens Sci 2002; 47:121-126.
45. Richards JR. Rhabdomyolisis and drugs of abuse. J Emerg Med 2000; 19:51-56.
46. Nicholson KL, Balster RL, GHB: a new and novel drug of abuse. Drug Alcohol Depend 2001; 63:1-22. An excellent review of γ-hydroxybutyrate, which has some clinical potential, and because it has a relatively safe profile and is easy to make at home will probably continue as an abused agent.
47. Kam PC, Yoong FF, Gamma-hydroxybutyric acid: an emerging recreational drug. Anaesthesia 1998; 53:1195-1198.
48. Sivilotti ML, Burns MJ, Aaron CK, Greenberg MJ. Pentobarbital for severe GHB withdrawal. Ann Emerg Med 2001; 38:660-665.
49. Rickert VI, Wiemann CM, Berenson AB. Flunitrazepam: more than a date rape drug. J Pediatr Adolesc Gynecol 2000; 13:37-42.
50. Gatzonis SD, Angelopoulos EK, Daskalopoulou EG, et al. Convulsive status epilepticus following abrupt high-dose benzodiazepine discontinuation. Drug Alcohol Depend 2000; 59:95-97.
51. Brammer G, Gibly R, Walter FG, et al. Continuous intravenous flumazenil infusion for benzodiazepine poisoning. Vet Hum Toxiool 2001; 42:280-281. Rohypnol and other benzodiazepines with intermediate to long half-lives can be treated with flumazenil infusion safely.
52. Snyder H, Sohwenzer KS, Pearlman R, et al. Serum and urine concentrations of flunitrazepam and metabolites after a single oral dose, by immunoassay and GC-MS. J Anal Toxicol 2001; 25:699-704. Gas chromatography is best, but the SBENZ tool can detect rohypnol up to 72 h after a single dose.
53. Yu B, Wang C, Liu J, et al. Adaptation to chronic PCP results in hyperfunctional NMDA and hypofunctional GABA(A) synaptic receptors. Neuroscience 2002; 113:1-10. This study explains the behavioral changes in phencyclidine abusers and offers insight into potential problems with anesthetizing chronic phencyclidine abusers.
54. Pal HR, Berry N, Kumar R, Ray R. Ketamine dependence. Anaesth Intens Care 2002; 30:382-384.
55. Giannini AJ, Underwood NA, Condon M. Acute ketamine intoxication treated by haloperidol: a preliminary study. Am J Ther 2000; 7:389-391.
56. Balster RL. Neural basis of inhalant abuse. Drug Alcohol Depend 1998; 51:207-214.
57. Gerasimov MR, Schiffer WK, Marstellar D, et al. Toluene inhalation produces regionally specific changes in extracellular dopamine. Drug Alcohol Depend 2002; 65:243-251.
58. Haberman PW, Noble JA, Dufour MC. Alcohol use in combination with cocaine, heroin, and methadone by medical examiner cases. J Stud Alcohol 1995; 56:344-347.
59. Myrick H, Brady KT, Malcolm R. New developments in the pharmacotherapy of alcohol dependence. Am J Addict 2001; 10 (Suppl):3-15.
60. de Arujo MS, Guerret S, Gerard F, et al. Quantitative studies on liver fibrosis and alpha-smooth muscle actin expression in heroin abusers. Cell Mol Biol (Noisy-le-grand) 1997; 43:589-596.
61. Macedo T, Ribeiro CA, Cotrim D, et al. Catecholamine and MHPG plasma levels, platelet MAO activity, and 3H-imipramine binding in heroin and cocaine addicts. Mol Neurobiol 1995; 11:21-29.
62. Hensel M, Kox WJ. Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anesthesia: a prospective study in methadone, heroin, codeine, and morphine addicts. Acta Anaesth Scand 2000; 44:326-333.
63. Elman I, D'Ambra MN, Krause S, et al. Ultra rapid opioid detoxification: effects on cardiopulmonary physiology, stress hormones and clinical outcomes. Drug Alcohol Depend 2001; 61:163-172. Side-effects include significant respiratory distress in the post-anesthetic phase.